Skip to content
CCEH
Bringing together Centers of Excellence to advance benign hematology research
CCEH
  • Centers
    • Cincinnati Center of Excellence in Molecular Hematology
    • Fred Hutchinson Cancer Center
    • Indiana University Cooperative Center of Excellence in Hematology
    • Center for Iron & Heme Disorders at The University of Utah School of Medicine
    • Yale Cooperative Center of Excellence in Hematology
  • News
    • Events
    • Multiomics Monday 2025
    • Featured Publications
    • Highlighted Cores
    • Newsletters
  • Funding
    • Funding
    • P&F Projects
      • 2024
      • 2023
      • 2022
      • 2021
      • 2020
  • Careers
  • Services
  • Protocols
  • Videos
    • Video Directory
    • CCEH YouTube Channel
  • About
Search:
  • Centers
    • Cincinnati Center of Excellence in Molecular Hematology
    • Fred Hutchinson Cancer Center
    • Indiana University Cooperative Center of Excellence in Hematology
    • Center for Iron & Heme Disorders at The University of Utah School of Medicine
    • Yale Cooperative Center of Excellence in Hematology
  • News
    • Events
    • Multiomics Monday 2025
    • Featured Publications
    • Highlighted Cores
    • Newsletters
  • Funding
    • Funding
    • P&F Projects
      • 2024
      • 2023
      • 2022
      • 2021
      • 2020
  • Careers
  • Services
  • Protocols
  • Videos
    • Video Directory
    • CCEH YouTube Channel
  • About

Krause Lab Blood Publication

You are here:
  1. Home
  2. Featured Publication
  3. Krause Lab Blood Publication
Congratulations to the Krause lab for their recent publication
in Blood
CDK9 phosphorylates RUNX1 to promote megakaryocytic fate in megakaryocytic-erythroid progenitors
Link to Publication ▸

Abstract Text:

The specification of megakaryocytic (Mk) or erythroid (E) lineages from primary human megakaryocytic-erythroid progenitors (MEPs) is crucial for hematopoietic homeostasis, yet the underlying mechanisms regulating fate specification remain elusive. In this study, we identify RUNX1 as a key modulator of gene expression during MEP fate specification. Overexpression of RUNX1 in primary human MEPs promotes Mk specification, whereas pan-RUNX inhibition favors E specification. Although total RUNX1 levels do not differ between Mk progenitors (MkPs) and E progenitors (ErPs), there are higher levels of serine-phosphorylated RUNX1 in MkPs than ErPs, and mutant RUNX1 with phosphorylated-serine/threonine mimetic mutations (RUNX1-4D) significantly enhances the functional efficacy of RUNX1. To model the effects of RUNX1 variants, we use human erythroleukemia (HEL) cell lines expressing wild-type (WT), phosphomimetic (RUNX1-4D), and nonphosphorylatable (RUNX1-4A) mutants showing that the 3 forms of RUNX1 differentially regulate expression of 2625 genes. Both WT and RUNX1-4D variants increase expression in 40%, and decrease expression in another 40%, with lesser effects of RUNX1-4A. We find a significant overlap between the upregulated genes in WT and RUNX1-4D-expressing HEL cells and those upregulated in primary human MkPs vs MEPs. Although inhibition of known RUNX1 serine/threonine kinases does not affect phosphoserine RUNX1 levels in primary MEPs, specific inhibition of cyclin dependent kinase 9 (CDK9) in MEPs leads to both decreased RUNX1 phosphorylation and increased E commitment. Collectively, our findings show that serine/threonine phosphorylation of RUNX1 promotes Mk fate specification and introduce a novel kinase for RUNX1 linking the fundamental transcriptional machinery with activation of a cell type-specific transcription factor.

Share this post
Share on FacebookShare on Facebook Share on XShare on X

Funding Agencies

National Institute of Diabetes and Digestive and Kidney Diseases

Social Media

  • Facebook
  • X
  • Instagram
  • Bluesky
  • YouTube

Centers

Cincinnati Center of Excellence in Molecular Hematology

Fred Hutchinson Cancer Center

Indiana University Cooperative Center of Excellence in Hematology

Center for Iron & Heme Disorders at The University of Utah School of Medicine

Yale Cooperative Center of Excellence in Hematology

Contact

Shilpa Hattangadi, MD

Program Director, Hematology
Extramural Training Activities
Project Scientist,
Cooperative Centers of Excellence in Hematology

CCEH

Copyright © 2025

Go to Top
×